Status:
COMPLETED
Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
Parkinson's Disease
Parkinson
Eligibility:
All Genders
40-85 years
Phase:
NA
Brief Summary
This study aims to investigate the effects of the Ketoflex 12/3 diet on motor and non-motor symptoms in patients with Parkinson's disease. Participants will follow the Ketoflex 12/3 dietary regimen, a...
Detailed Description
Parkinson's disease is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. Emerging evidence suggests that dietary interventions, particularly ketogenic diets and i...
Eligibility Criteria
Inclusion
- Diagnosed with Parkinson's disease
- Age between 40-85 years
- Native Turkish speakers
- Able to comply with the study protocol
Exclusion
- History of alcohol or substance dependence
- Diagnosis of chronic renal failure
- Presence of neuromuscular disorders
- Having amalgam dental fillings and/or failure to remove them according to the SMART protocol
- Severe vitamin deficiencies that have not been corrected prior to the study
Key Trial Info
Start Date :
March 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06892418
Start Date
March 30 2024
End Date
November 30 2024
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
İstanbul Medipol Üniversitesi
Istanbul, Turkey (Türkiye), 34214